Raptor Pharmaceutical Inc. Adds Three Biopharmaceutical Leaders to Its Board of Directors

NOVATO, Calif., April 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced today the appointments of Suzanne L. Bruhn, Ph.D., Vijay B. Samant and Timothy P. Walbert to the Company's board of directors. The appointments expand Raptor's Board to eight members.